Since the Food and Drug Administration first (FDA) began approving commercial applications of CAR-T and CRISPR cell and gene-based therapies (CGT) over the last six years, there has been a growing…| Penn LDI
Hoag Levins is a journalist, photographer, and digital content producer who joined Penn LDI in 2011.| Penn LDI